Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05197036 · ClinicalTrials.gov registry record

A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis

A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Smith & Nephew.

Active
Registry status
299
Enrollment target
18
Study locations

NCT05197036: Active study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Smith & Nephew.

NCT05197036 is a study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Smith & Nephew. The registered enrollment target is 299 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 18 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05197036, a study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Smith & Nephew.

ACTIVE NOT RECRUITING
Registry status
299 participants
Enrollment target
18
Study locations

Study Summary

A clinical trial investigating the safety and effectiveness of Smith and Nephew's FDA-approved Porous Total Knee System, which is used to replace worn away and diseased knee joints. The aim of this study is to show that most patients who receive the Porous Total Knee System have reduced pain, greater mobility and a long-lasting implant post-surgery.

Primary Outcome

Survivorship of the femoral and/or tibial component of the implant is defined as the cumulative proportion of femoral and/or tibial components without a revision.

Interventions

  • PROCEDURE Total Knee Arthroplasty

Study Locations (18)

New York

  • Syracuse Orthopedic Specialists - East Syracuse
  • NYU Langone Health Orthopedic Hospital - New York
  • Columbia University - New York

Georgia

  • Emory Orthopaedics and Spine Hospital - Atlanta

Massachusetts

  • Massachusetts General Hospital - Boston

Michigan

  • The Core Institute - Novi

North Carolina

  • Duke Health - Morrisville

Oregon

  • Oregon Health & Science University - Portland

South Carolina

  • Medical University of South Carolina - Charleston

Tennessee

  • Erlanger Health - Chattanooga

Trial Details

FieldValue
Enrollment Target 299 participants
Start Date 2021-12-21
Est. Completion 2033-12-25
Smith & Nephew

72 total trials

What the registry record for NCT05197036 still lists

NCT05197036 is an observational study that tracks outcomes without assigning an intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower).

The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Total Knee Arthroplasty is the first listed.

NCT05197036 lists 18 locations in 16 states (New York, Georgia, Massachusetts).

Frequently Asked Questions

What is clinical trial NCT05197036 about?

NCT05197036 is a clinical study titled "A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis". A clinical trial investigating the safety and effectiveness of Smith and Nephew's FDA-approved Porous Total Knee System, which is used to replace worn away and diseased knee joints. The aim of this study is to show that most patients who receive the Porous Total Knee System have reduced pain, greate...

What is the current status of trial NCT05197036?

This trial is currently active not recruiting. The enrollment target is 299 participants. The study started on 2021-12-21. Estimated completion is 2033-12-25.

What conditions does trial NCT05197036 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Post Traumatic Arthritis.

What interventions are being tested in trial NCT05197036?

The interventions under investigation include: Total Knee Arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT05197036?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05197036 being conducted?

This trial has 18 study locations across Georgia, Massachusetts, Michigan, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05197036's enrollment target sits among peer trials

299 61st of 197 higher than 137 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05197036, the US trial registry maintained by the National Library of Medicine. NCT05197036 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.